Classification of Multiple Diseases on Body CT Scans Using Weakly Supervised Deep Learning.

CT Diagnosis/Classification/Application Domain Semisupervised Learning Whole-Body Imaging

Journal

Radiology. Artificial intelligence
ISSN: 2638-6100
Titre abrégé: Radiol Artif Intell
Pays: United States
ID NLM: 101746556

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 20 01 2021
revised: 04 10 2021
accepted: 15 11 2021
entrez: 11 2 2022
pubmed: 12 2 2022
medline: 12 2 2022
Statut: epublish

Résumé

To design multidisease classifiers for body CT scans for three different organ systems using automatically extracted labels from radiology text reports. This retrospective study included a total of 12 092 patients (mean age, 57 years ± 18 [standard deviation]; 6172 women) for model development and testing. Rule-based algorithms were used to extract 19 225 disease labels from 13 667 body CT scans performed between 2012 and 2017. Using a three-dimensional DenseVNet, three organ systems were segmented: lungs and pleura, liver and gallbladder, and kidneys and ureters. For each organ system, a three-dimensional convolutional neural network classified each as no apparent disease or for the presence of four common diseases, for a total of 15 different labels across all three models. Testing was performed on a subset of 2158 CT volumes relative to 2875 manually derived reference labels from 2133 patients (mean age, 58 years ± 18; 1079 women). Performance was reported as area under the receiver operating characteristic curve (AUC), with 95% CIs calculated using the DeLong method. Manual validation of the extracted labels confirmed 91%-99% accuracy across the 15 different labels. AUCs for lungs and pleura labels were as follows: atelectasis, 0.77 (95% CI: 0.74, 0.81); nodule, 0.65 (95% CI: 0.61, 0.69); emphysema, 0.89 (95% CI: 0.86, 0.92); effusion, 0.97 (95% CI: 0.96, 0.98); and no apparent disease, 0.89 (95% CI: 0.87, 0.91). AUCs for liver and gallbladder were as follows: hepatobiliary calcification, 0.62 (95% CI: 0.56, 0.67); lesion, 0.73 (95% CI: 0.69, 0.77); dilation, 0.87 (95% CI: 0.84, 0.90); fatty, 0.89 (95% CI: 0.86, 0.92); and no apparent disease, 0.82 (95% CI: 0.78, 0.85). AUCs for kidneys and ureters were as follows: stone, 0.83 (95% CI: 0.79, 0.87); atrophy, 0.92 (95% CI: 0.89, 0.94); lesion, 0.68 (95% CI: 0.64, 0.72); cyst, 0.70 (95% CI: 0.66, 0.73); and no apparent disease, 0.79 (95% CI: 0.75, 0.83). Weakly supervised deep learning models were able to classify diverse diseases in multiple organ systems from CT scans.

Identifiants

pubmed: 35146433
doi: 10.1148/ryai.210026
pmc: PMC8823458
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e210026

Subventions

Organisme : NCI NIH HHS
ID : P30 CA014236
Pays : United States
Organisme : NIBIB NIH HHS
ID : P41 EB028744
Pays : United States

Informations de copyright

2022 by the Radiological Society of North America, Inc.

Déclaration de conflit d'intérêts

Disclosures of Conflicts of Interest: F.I.T. No relevant relationships. V.M.D. No relevant relationships. R.H. No relevant relationships. M.A.M. No relevant relationships. W.F. No relevant relationships. E.S. No relevant relationships. G.D.R. No relevant relationships. J.Y.L. MAIA Erasmus and University of Girona fellowship covered part of F.I.T.'s graduate stipend while he was a visiting scholar; NVIDIA GPU card given to the laboratory.

Références

Med Phys. 2013 Apr;40(4):043701
pubmed: 23556927
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
Artif Intell Med. 2019 Jun;97:79-88
pubmed: 30477892
Radiol Artif Intell. 2021 Sep 29;3(6):e200274
pubmed: 34870213
Radiology. 2019 Feb;290(2):456-464
pubmed: 30398430
Ann Intern Med. 2018 Sep 18;169(6):357-366
pubmed: 30105375
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Lancet Digit Health. 2020 Mar;2(3):e138-e148
pubmed: 33334578
Sci Data. 2019 Dec 12;6(1):317
pubmed: 31831740
Radiology. 2019 Dec;293(3):607-617
pubmed: 31592731
Radiol Artif Intell. 2019 Aug 7;1(5):e180052
pubmed: 33937800
IEEE Trans Med Imaging. 2021 Oct;40(10):2759-2770
pubmed: 33370236
Ulster Med J. 2012 Jan;81(1):3-9
pubmed: 23536732
Radiology. 2019 Oct;293(1):38-46
pubmed: 31385754
Radiology. 2020 Apr;295(1):4-15
pubmed: 32068507
Sci Rep. 2017 Apr 19;7:46479
pubmed: 28422152
EClinicalMedicine. 2019 Mar 17;9:52-59
pubmed: 31143882
Med Image Anal. 2021 Jan;67:101857
pubmed: 33129142
IEEE Trans Med Imaging. 2018 Aug;37(8):1822-1834
pubmed: 29994628
Nat Commun. 2021 Mar 25;12(1):1880
pubmed: 33767174
J Med Imaging (Bellingham). 2018 Jul;5(3):036501
pubmed: 30035154

Auteurs

Fakrul Islam Tushar (FI)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Vincent M D'Anniballe (VM)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Rui Hou (R)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Maciej A Mazurowski (MA)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Wanyi Fu (W)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Ehsan Samei (E)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Geoffrey D Rubin (GD)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Joseph Y Lo (JY)

Center for Virtual Imaging Trials, Carl E. Ravin Advanced Imaging Laboratories, Department of Radiology and Department of Electrical and Computer Engineering, Duke University, 2424 Erwin Rd, Studio 302, Durham, NC 27705 (F.I.T., R.H., M.A.M., W.F., E.S., J.Y.L.); Department of Radiology, Duke University, Durham, NC (V.M.D.); and Department of Medical Imaging, University of Arizona, Tucson, Ariz (G.D.R.).

Classifications MeSH